European Nuclear Medicine Guide

7. Neuroendocrine Tumors

• 7.1.

  Indication: neuroendocrine tumours
• 7.2.

  [177Lu]Lutetium ([177Lu]Lu-DOTA0, Tyr3) oxodotreotide
• 7.3.

  [90Y]Yttrium ([90Y]Y-DOTA0, Tyr3) octreotide or [90Y]Y-DOTA-TOC